John Armitage's BSX Position Overview
John Armitage (via Egerton Capital (Uk) Llp) currently holds 5.39 M shares of Boston Scientific Corporation (BSX) worth $513.47 M, representing 5.58% of the portfolio. First purchased in 2025-Q2, this short-term holding has been held for 3 quarters.
Based on 13F filings, John Armitage has maintained this position in BSX for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 3.67 M shares.
Analysis based on 13F filings available since 2013 Q2
John Armitage's Boston Scientific Corporation (BSX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Boston Scientific Corporation (BSX) Trades by John Armitage
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +72,580 | Add 1.37% | 5.39 M | $95.35 |
| Q3 2025 | +3.67 M | Add 223.74% | 5.31 M | $97.63 |
| Q2 2025 | +1.64 M | New Buy | 1.64 M | $107.41 |
John Armitage's Boston Scientific Corporation Investment FAQs
John Armitage first purchased Boston Scientific Corporation (BSX) in Q2 2025, acquiring 1,640,956 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
John Armitage has held Boston Scientific Corporation (BSX) for 3 quarters since Q2 2025.
John Armitage's largest addition to Boston Scientific Corporation (BSX) was in Q3 2025, adding 5,312,504 shares worth $518.66 M.
According to the latest 13F filing for Q4 2025, John Armitage's firm, Egerton Capital (Uk) Llp, owns 5,385,084 shares of Boston Scientific Corporation (BSX), valued at approximately $513.47 M.
As of the Q4 2025 filing, Boston Scientific Corporation (BSX) represents approximately 5.58% of John Armitage's publicly disclosed stock portfolio, making it one of their key holdings.
John Armitage's peak holding in Boston Scientific Corporation (BSX) was 5,385,084 shares, as reported at the end of Q4 2025.